U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157527) titled 'Impact of Sacubitril/Valsartan on LV Diastolic Function in HFrEF' on Aug. 28.
Brief Summary: This prospective cohort study evaluates the effects of six months of sacubitril/valsartan (ARNI) therapy on left ventricular diastolic function in patients with heart failure with reduced ejection fraction (HFrEF) using transthoracic echocardiography. It aims to correlate echocardiographic parameters with clinical status and systolic function among Egyptian patients treated at two cardiology centers.
Study Start Date: June 01, 2026
Study Type: OBSERVATIONAL
Condition:
Left Ventricular Diastolic Function
Recruitment Status: NOT_YET_RECRU...